Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis-The IMPROVE Study. (2021)
Attributed to:
Understanding the excess risk of cardiometabolic disease in individuals with serious mental illness
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/biomedicines9070841
PubMed Identifier: 34356905
Publication URI: http://europepmc.org/abstract/MED/34356905
Type: Journal Article/Review
Volume: 9
Parent Publication: Biomedicines
Issue: 7
ISSN: 2227-9059